Daniel Aghion - 05 Jun 2025 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role: Director
Signature: /s/ Daniel Aghion
Issuer symbol: ORMP
Transactions as of: 05 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 09 Jun 2025, 16:08:22 UTC
Previous filing: 30 Jan 2024
Next filing: 02 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Aghion Daniel	Director	1185 AVENUE OF THE AMERICAS, NEW YORK	/s/ Daniel Aghion	09 Jun 2025	0002004805

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORMP	Common Stock	Award		+30,000	+77%		68,820	05 Jun 2025	Direct	F1
transaction	ORMP	Common Stock	Award		+8,371	+12%		77,191	05 Jun 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	. Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2	Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.